The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.00

Today's change-0.20 -0.33%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.00

Today's change-0.20 -0.33%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc down (U.S.)$0.20

AbbVie Inc closed lower Friday, dropping (U.S.)$0.20 or 0.33% to (U.S.)$61.00. Shares have lost 0.68% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 5.08% during the last year.

Key company metrics

  • Open(U.S.) $61.03
  • Previous close(U.S.) $61.20
  • High(U.S.) $61.45
  • Low(U.S.) $60.48
  • Bid / Ask-- / --
  • YTD % change+2.97%
  • Volume13,052,698
  • Average volume (10-day)6,366,543
  • Average volume (1-month)6,276,843
  • Average volume (3-month)8,078,832
  • 52-week range(U.S.) $45.45 to (U.S.) $71.60
  • Beta1.49
  • Trailing P/E18.28×
  • P/E 1 year forward12.45×
  • Forward PEG0.72×
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield3.74%
  • Trailing EPS(U.S.) $3.34
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,4005,9445,4755,040
Total other revenue--------
Total revenue6,4005,9445,4755,040
Gross profit4,9254,8664,5594,098
Total cost of revenue1,4751,078916942
Total operating expense4,2874,0593,6233,353
Selling / general / administrative1,7371,4741,7031,354
Research & development1,0751,418981811
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0023246
Other operating expenses, total00----
Operating income2,1131,8851,8521,687
Interest income (expense), net non-operating-208-207-172-132
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9241,6471,6781,396
Income after tax1,5171,2391,3661,022
Income tax, total407408312374
Net income1,5171,2391,3661,022
Total adjustments to net income--------
Net income before extra. items1,5171,2391,3661,022
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,5171,2391,3661,022
Inc. avail. to common incl. extra. items1,5171,2391,3661,022
Diluted net income1,5171,2391,3661,022
Dilution adjustment--------
Diluted weighted average shares1,6431,6641,6331,608
Diluted EPS excluding extraordinary itemsvalue per share0.920.740.840.64
Dividends per sharevalue per share0.570.510.510.51
Diluted normalized EPSvalue per share0.920.740.850.77